SCHADE CHRISTIAN S 4
4 · Omega Therapeutics, Inc. · Filed Feb 9, 2024
Insider Transaction Report
Form 4
SCHADE CHRISTIAN S
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-07+512,848→ 512,848 totalExercise: $3.59Exp: 2034-02-06→ Common Stock (512,848 underlying)
Footnotes (1)
- [F1]The option vested and became exercisable as to 14.28% of the underlying shares on February 7, 2024 and vests and will become exercisable in thirty-six (36) substantially equal monthly installments thereafter, such that the option shall be fully vested and exercisable on February 7, 2027, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.